Endovascular Engineering FDA Record
- Latest inspection NAI · Jul 24, 2026
- No warning letters matched by name
Endovascular Engineering has 0 FDA recalls, 2 inspections, 4 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Endovascular Engineering" is on file.
- Latest inspection
- Jul 24, 2026 · NAI
- Latest 510(k)
- Oct 11, 2026
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 0 | Drug: Nov 20, 2026 (checked Nov 22, 2026, unchanged); Device: Nov 20, 2026 (checked Nov 22, 2026, unchanged); Food: Nov 22, 2026 | Drug: File dated Nov 19, 2026; Device: File dated Nov 19, 2026; Food: File dated Nov 19, 2026 | Current |
| 510(k) clearances | 4 | Nov 22, 2026 | File dated Nov 18, 2026 | Current |
| Inspections | 2 | Nov 22, 2026 | Newest record Nov 9, 2026 | Current |
| Compliance actions | 0 | Nov 22, 2026 | Newest record Nov 13, 2026 | Current |
Reviewing Endovascular Engineering as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Endovascular Engineering yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Jul 24, 2026 | Menlo Park, CA | Devices | No Action Indicated (NAI) | 3026567963 |
| Jul 21, 2026 | Menlo Park, CA | Devices | Official Action Indicated (OAI) | 3026567963 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3026567963 | Menlo Park, CA | 2 | Jul 24, 2026 |
Endovascular Engineering and the FDA: common questions
Has Endovascular Engineering received an FDA warning letter?
No FDA warning letter addressed to the name "Endovascular Engineering" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has Endovascular Engineering received an FDA Form 483?
FDA has not published a Form 483 for "Endovascular Engineering" in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Endovascular Engineering?
The most recent FDA inspection on file ended Jul 24, 2026 at Menlo Park, CA and was classified NAI. FDA has 2 inspections of Endovascular Engineering on file, 1 of them classified OAI (official action indicated).
Need more than this page shows? Ask about Endovascular Engineering in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.